Individualized medicine - our (lack of) understanding

被引:4
作者
Windeler, Juergen [1 ]
机构
[1] Inst Qualitat & Wirtschaftlichkeit Gesundheitswes, Dillenburger Str 27, D-51105 Cologne, Germany
来源
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN | 2012年 / 106卷 / 01期
关键词
individualized medicine; personalized medicine; individuality; evidence based medicine; diagnostic test;
D O I
10.1016/j.zefq.2011.08.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
A so called individualized or personalized medicine is currently stimulating peculiar attention. The terms promise better, i.e. more successful, medical treatment with fewer side effects for the future. The present article discusses the biologic concept underlying the terms as well as the promises connected with it and places the terms into the broader context of diagnostic methods. It is pointed out that an assessment of methods called individualized medicine can and should be carried out in adherence to the same methodological principles as they apply to the assessment of other diagnostic tests. Even individualized medicine needs to be subjected to the standard evaluation and review procedures of evidence based medicine.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 9 条
[1]  
Golubnitschaja O, 2010, PERSONALISIERTE MED, P37
[2]   Individualised medicine - potentials and need for action [J].
Huesing, Baerbel .
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2010, 104 (10) :727-731
[3]  
Kobberling J, 1992, WISSENSCHAFT MED SEL, P83
[4]   Various randomized designs can be used to evaluate medical tests [J].
Lijmer, Jeroen G. ;
Bossuyt, Patrick M. M. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (04) :364-373
[5]   Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction - Results from a randomized trial [J].
Morrow, DA ;
Cannon, CP ;
Rifai, N ;
Frey, MJ ;
Vicari, R ;
Lakkis, N ;
Robertson, DH ;
Hille, DA ;
DeLucca, PT ;
DiBattiste, PM ;
Demopoulos, LA ;
Weintraub, WS ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19) :2405-2412
[6]  
Niederlag W, 2010, PERSONALISIERTE MED
[7]   Evidence based medicine: What it is and what it isn't - It's about integrating individual clinical expertise and the best external evidence [J].
Sackett, DL ;
Rosenberg, WMC ;
Gray, JAM ;
Haynes, RB ;
Richardson, WS .
BRITISH MEDICAL JOURNAL, 1996, 312 (7023) :71-72
[8]   Clinical trial designs for predictive marker validation in cancer treatment trials [J].
Sargent, DJ ;
Conley, BA ;
Allegro, C ;
Collette, L .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :2020-2027
[9]   Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status [J].
Van Cutsem, Eric ;
Kohne, Claus-Henning ;
Lang, Istvan ;
Folprecht, Gunnar ;
Nowacki, Marek P. ;
Cascinu, Stefano ;
Shchepotin, Igor ;
Maurel, Joan ;
Cunningham, David ;
Tejpar, Sabine ;
Schlichting, Michael ;
Zubel, Angela ;
Celik, Ilhan ;
Rougier, Philippe ;
Ciardiello, Fortunato .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :2011-2019